Drug Found to Prolong Lives of Melanoma Patients Is Approved
The New York Times reports that Yervoy, the first drug shown to prolong the lives of people with the skin cancer melanoma, recently won approval from the FDA. Yervoy is an example of an emerging class of treatments known as immunotherapy that harness the body’s own immune system to fight tumors.
Related Links
Link to The New York Times article